510(k) Report

510(k) · Cleared

Cleared

ACR LAB Urine Analysis Test System

K182384510(k) TraditionalCleared Jul 26, 2019329-day reviewClass II21 CFR 862.1225

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Healthy.Io, Ltd. · JFY Enzymatic Method, Creatinine

Cleared on Jul 26, 2019 as substantially equivalent to K142391 (ACON Laboratories, Inc., 2014) after a 329-day review. Its family tree reaches back 5 generations to 1989. 1 later device descends from it.

Decided
Jul 26, 2019
Review
329 days
Class
Class II
Product code
JFY
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K890577 (1989). 10 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 5 generations backK890577 Kenlor Liquid Urine ControlKenlor Industries, Inc. · 1989
  2. 4 generations backK965171 Liquichek Urianlysis Control (Cat. NO. 420,421,422,425,426)Bio-Rad · 1997
  3. 3 generations backK031231 Liquicheck Urinalysis Control Bilevel, Model 435, Liquichek…Bio-Rad · 2003
  4. 2 generations backK070848 Liquichek Urinalysis Control (BI-Level), Control LEVEL1, Level…Bio-Rad, Diagnostics Grp. · 2007
  5. 1 generation backK142391 Mission U120 Ultra Urine Analyzer, Mission Urinalysis Reagent Strips…ACON Laboratories, Inc. · 2014
  6. This deviceK182384 ACR LAB Urine Analysis Test SystemHealthy.Io, Ltd. · 2019
  7. Descendant · cites it directly · 0 of its ownK252619 Qscheck UisacrQstag, Inc. · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K252619Qscheck UisacrQstag, Inc. · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K890577Kenlor Liquid Urine ControlKenlor Industries, Inc.1989—
−4K965171Liquichek Urianlysis Control (Cat. NO. 420,421,422,425,426)Bio-Rad1997—
−3K031231Liquicheck Urinalysis Control Bilevel, Model 435, Liquichek Urinalysis Control…Bio-Rad2003—
−2K070848Liquichek Urinalysis Control (BI-Level), Control LEVEL1, Level 2,Minipak…Bio-Rad, Diagnostics Grp.2007—
−1K142391Mission U120 Ultra Urine Analyzer, Mission Urinalysis Reagent Strips (…ACON Laboratories, Inc.2014—
0 (this device)K182384ACR LAB Urine Analysis Test SystemHealthy.Io, Ltd.2019—
+1K252619Qscheck UisacrQstag, Inc.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199610
199710
199910
200310

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K182384, 1989–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JFY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JFY device

  1. #1 K252619 Qscheck Uisacrscore 12.4 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K142391Mission U120 Ultra Urine Analyzer, Mission Urinalysis Reagent Strips (…
Summary page 4
…device: Manufacturer Device 510(k) Number ACON Laboratories Inc. Mission U120 Ultra Urine Analyzer k142391 and Mission Urinalysis Reagent Strips (Microalbumin/Creatinine)…
ACON Laboratories, Inc.2014—

Also cleared against K142391: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K252619Qscheck UisacrQstag, Inc.20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 30 years and passes through 5 companies; a new generation was cleared every 6.4 years on median.
  • 1 of the 10 ancestors has a recall of any class.
  • Of its descendants, K252619 (Qstag, Inc., 2026) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K142391.

How does its category compare?

All JFY devices

JFY Enzymatic Method, Creatinine: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · JFY

2in 2021

2007: 82008: 42009: 32011: 22014: 22016: 12017: 12018: 22019: 22021: 22026 (partial year): 1
2007high 8 (2007) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JFY

59in 2009

2007: 193 days median2008: 170 days median2009: 59 days median
2007high 193 (2007) · low 59 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JFY

1in 2013

2008: 22009: 32010: 32013: 1
2007high 3 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JFY

61in 2025

2007: 12008: 42009: 222010: 222011: 422012: 242013: 392014: 42015: 72016: 162017: 162018: 342019: 562020: 342021: 572022: 92023: 362024: 342025: 61
2007high 61 (2025) · low 1 (2007)2025

MAUDE reports naming product code JFY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007819301
2008417024
2009359322
20100—322
20112—042
20120—024
20130—139
20142—04
20150—07
20161—016
20171—016
20182—034
20192—056
20200—034
20212—057
20220—09
20230—036
20240—034
20250—061
20261—0—

What is it indicated for?

The ACR | LAB Urine Analysis Test System is comprised of a smartphone application, a proprietary Color-Board, and ACR Reagent Strips. It is intended for the semi-quantitative detection of albumin and creatinine in urine, as well as the presentation of their ratio. The ACR | LAB Urine Analysis Test System is intended for in-vitro diagnostic use by a healthcare professional in a point of care setting. These results may be used in conjunction with clinical evaluation as an aid in the diagnosis for kidney function.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K182384: ACR LAB Urine Analysis Test System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K182384

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026